The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

E.S. Kropacheva

Institute of Cardiology named after A.L. Myasnikov of National Medical Research Center for Cardiology, Moscow, Russia

O.A. Zemlyanskaya

Institute of the Cardiology named after A.L. Myasnikov of National Medical Research Center for Cardiology, Moscow, Russia

A.B. Dobrovol'skiĭ

Rossiĭskiĭ kardiologicheskiĭ nauchno-proizvodstvennyĭ kompleks Minzdravsotsrazvitiia RF, Moskva

E.P. Panchenko

Rossiĭskiĭ kardiologicheskiĭ nauchno-proizvodstvennyĭ kompleks Minzdravsotsrazvitiia RF, Moskva

Prognostic value of the SAMe-TT2R2 index and Charlson Comorbidity Index for the non-target anticoagulation and risk of thrombotic events in warfarin-treated patients (results of 10-years prospective study)

Authors:

E.S. Kropacheva, O.A. Zemlyanskaya, A.B. Dobrovol'skiĭ, E.P. Panchenko

More about the authors

Journal: Russian Cardiology Bulletin. 2019;14(1): 23‑32

Views: 985

Downloaded: 33


To cite this article:

Kropacheva ES, Zemlyanskaya OA, Dobrovol'skiĭ AB, Panchenko EP. Prognostic value of the SAMe-TT2R2 index and Charlson Comorbidity Index for the non-target anticoagulation and risk of thrombotic events in warfarin-treated patients (results of 10-years prospective study). Russian Cardiology Bulletin. 2019;14(1):23‑32. (In Russ.)
https://doi.org/10.17116/Cardiobulletin20191401123

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.